Schonfeld Strategic Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6K | Buy |
+16,126
| New | +$14.6K | ﹤0.01% | 1849 |
|
|
2023
Q2 | – | Sell |
-22,300
| Closed | -$33.5K | – | 2172 |
|
|
2023
Q1 | $33.5K | Buy |
+22,300
| New | +$33.5K | ﹤0.01% | 1741 |
|
|
2021
Q2 | – | Sell |
-33,574
| Closed | -$78K | – | 2078 |
|
|
2021
Q1 | $78K | Buy |
33,574
+15,841
| +89% | +$36.8K | ﹤0.01% | 1649 |
|
|
2020
Q4 | $32K | Buy |
+17,733
| New | +$32K | ﹤0.01% | 1477 |
|